Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Macromolecular Bioscience|September 14, 2017
Solid Tumor Immunotherapy with T Cell Engager-Armed Oncolytic VirusesEleanor M Scott, Margaret R Duffy, Joshua D Freedman, et al.Methods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Use of Liquid Patient Ascites Fluids as a Preclinical Model for Oncolytic Virus ActivityEleanor M Scott, Sally Frost, Hena Khalique, et al.EMBO Molecular Medicine|June 22, 2017
Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsiesJoshua D Freedman, Joachim Hagel, Eleanor M Scott, et al.Journal for Immunotherapy of Cancer|November 23, 2019
Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samplesEleanor M Scott, Egon J Jacobus, Brian Lyons, et al.Cancer Research|November 20, 2018
An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal CellsJoshua D Freedman, Margaret R Duffy, Janet Lei-Rossmann, et al.Nature Medicine|August 19, 2020
A dynamic COVID-19 immune signature includes associations with poor prognosisAdam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.Nature Medicine|November 28, 2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosisAdam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.Pageof 1